• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients.

作者信息

Cecchi Irene, Perez-Sanchez Carlos, Sciascia Savino, Radin Massimo, Arias de la Rosa Ivan, Barbarroja Puerto Nuria, Scudeler Luca, Perez-Sanchez Laura, Patiño Trives Alejandra Maria, Aguirre Zamorano Maria Angeles, Menegatti Elisa, Roccatello Dario, Lopez-Pedrera Chary

机构信息

Center of Research of Immuno-pathology and Rare Diseases- Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, Department of Clinical and Biological Sciences, and SCDU Nephrology and Dialysis, University of Turin and S. Giovanni BoscoHospital, Turin, Italy.

Rheumatology service, IMIBIC/Reina SofiaHospital/University of Cordoba, Cordoba, Spain.

出版信息

Autoimmun Rev. 2020 Apr;19(4):102488. doi: 10.1016/j.autrev.2020.102488. Epub 2020 Feb 13.

DOI:10.1016/j.autrev.2020.102488
PMID:32062026
Abstract
摘要

相似文献

1
Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients.循环微RNA作为监测系统性红斑狼疮患者体内利妥昔单抗治疗反应的潜在生物标志物。
Autoimmun Rev. 2020 Apr;19(4):102488. doi: 10.1016/j.autrev.2020.102488. Epub 2020 Feb 13.
2
Predictive and prognostic factors influencing outcomes of rituximab therapy in systemic lupus erythematosus (SLE): A systematic review.预测和预后因素对系统性红斑狼疮（SLE）利妥昔单抗治疗结局的影响：系统评价。
Semin Arthritis Rheum. 2017 Dec;47(3):384-396. doi: 10.1016/j.semarthrit.2017.04.010. Epub 2017 May 5.
3
Diagnostic significance of circulating miRNAs in systemic lupus erythematosus.循环 miRNA 在系统性红斑狼疮中的诊断意义。
PLoS One. 2019 Jun 4;14(6):e0217523. doi: 10.1371/journal.pone.0217523. eCollection 2019.
4
Changes in the Expression of Circulating microRNAs in Systemic Lupus Erythematosus Patient Blood Plasma After Passing Through a Plasma Adsorption Membrane.系统性红斑狼疮患者血浆通过血浆吸附膜后循环微RNA表达的变化
Ther Apher Dial. 2018 Jun;22(3):278-289. doi: 10.1111/1744-9987.12695. Epub 2018 Jun 6.
5
Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus.利妥昔单抗治疗对儿童期起病的系统性红斑狼疮难治性血细胞减少症有快速且持久的反应。
Lupus. 2015 Aug;24(9):966-72. doi: 10.1177/0961203315578764. Epub 2015 Mar 24.
6
Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus.抗CD20抗体利妥昔单抗治疗难治性系统性红斑狼疮患者的疗效和安全性。
Lupus. 2018 Apr;27(5):802-811. doi: 10.1177/0961203317749047. Epub 2018 Jan 7.
7
The effects of rituximab on the lipid profile of patients with active systemic lupus erythematosus: results from a nationwide cohort in Spain (LESIMAB).利妥昔单抗对活动性系统性红斑狼疮患者血脂谱的影响：来自西班牙一项全国性队列研究（LESIMAB）的结果
Lupus. 2014 Sep;23(10):1014-22. doi: 10.1177/0961203314534909. Epub 2014 May 15.
8
Current role of rituximab in systemic lupus erythematosus.利妥昔单抗在系统性红斑狼疮中的当前作用。
Int J Rheum Dis. 2015 Feb;18(2):154-63. doi: 10.1111/1756-185X.12463. Epub 2014 Dec 19.
9
Safety and efficacy of rituximab in childhood-onset systemic lupus erythematosus and other rheumatic diseases.利妥昔单抗在儿童期起病的系统性红斑狼疮及其他风湿性疾病中的安全性和有效性。
J Rheumatol. 2015 Mar;42(3):541-6. doi: 10.3899/jrheum.140863. Epub 2015 Jan 15.
10
Efficacy and safety of rituximab in Japanese patients with systemic lupus erythematosus and lupus nephritis who are refractory to conventional therapy.利妥昔单抗在对传统治疗难治的日本系统性红斑狼疮和狼疮性肾炎患者中的疗效和安全性。
Mod Rheumatol. 2016;26(1):80-6. doi: 10.3109/14397595.2015.1060665. Epub 2015 Aug 19.

引用本文的文献

1
Biomarkers in Systemic Lupus Erythematosus along with Metabolic Syndrome.系统性红斑狼疮与代谢综合征中的生物标志物
J Clin Med. 2024 Mar 29;13(7):1988. doi: 10.3390/jcm13071988.
2
The role of non-coding RNA in lupus nephritis.非编码 RNA 在狼疮肾炎中的作用。
Hum Cell. 2023 May;36(3):923-936. doi: 10.1007/s13577-023-00883-w. Epub 2023 Feb 25.
3
UC-BSCs Exosomes Regulate Th17/Treg Balance in Patients with Systemic Lupus Erythematosus via miR-19b/KLF13.UC-BSCs 外泌体通过 miR-19b/KLF13 调节系统性红斑狼疮患者的 Th17/Treg 平衡。
Cells. 2022 Dec 19;11(24):4123. doi: 10.3390/cells11244123.
4
MicroRNAs in Lupus Nephritis-Role in Disease Pathogenesis and Clinical Applications.微小 RNA 在狼疮肾炎中的作用——疾病发病机制和临床应用。
Int J Mol Sci. 2021 Oct 4;22(19):10737. doi: 10.3390/ijms221910737.
5
Role of microRNAs in the Development of Cardiovascular Disease in Systemic Autoimmune Disorders.微小 RNA 在系统性自身免疫性疾病中心血管疾病发展中的作用。
Int J Mol Sci. 2020 Mar 16;21(6):2012. doi: 10.3390/ijms21062012.